152 related articles for article (PubMed ID: 35306364)
1. Characterization of the modification of Kelch-like ECH-associated protein 1 by different fumarates.
Qu L; Guo M; Zhang H; Chen X; Wei H; Jiang L; Li J; Chen Z; Dai S; Chen Y
Biochem Biophys Res Commun; 2022 May; 605():9-15. PubMed ID: 35306364
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro.
Brennan MS; Matos MF; Li B; Hronowski X; Gao B; Juhasz P; Rhodes KJ; Scannevin RH
PLoS One; 2015; 10(3):e0120254. PubMed ID: 25793262
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
Unni S; Deshmukh P; Krishnappa G; Kommu P; Padmanabhan B
FEBS J; 2021 Mar; 288(5):1599-1613. PubMed ID: 32672401
[TBL] [Abstract][Full Text] [Related]
4. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.
Wipke BT; Hoepner R; Strassburger-Krogias K; Thomas AM; Gianni D; Szak S; Brennan MS; Pistor M; Gold R; Chan A; Scannevin RH
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33468560
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U
Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575
[TBL] [Abstract][Full Text] [Related]
6. Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary.
Akino N; Wada-Hiraike O; Isono W; Terao H; Honjo H; Miyamoto Y; Tanikawa M; Sone K; Hirano M; Harada M; Hirata T; Hirota Y; Koga K; Oda K; Fujii T; Osuga Y
Reprod Biol Endocrinol; 2019 Feb; 17(1):23. PubMed ID: 30760288
[TBL] [Abstract][Full Text] [Related]
7. Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2-Dependent Manner.
Sano A; Kakazu E; Hamada S; Inoue J; Ninomiya M; Iwata T; Tsuruoka M; Sato K; Masamune A
Hepatology; 2021 Sep; 74(3):1271-1286. PubMed ID: 33724516
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease by modifying the Nrf2-Keap1 pathway.
Kobayashi K; Tomiki H; Inaba Y; Ichikawa M; Kim BS; Koh CS
Int Immunol; 2015 Jul; 27(7):333-44. PubMed ID: 25721871
[TBL] [Abstract][Full Text] [Related]
9. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.
Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998
[TBL] [Abstract][Full Text] [Related]
10. Recent progress and applications of small molecule inhibitors of Keap1-Nrf2 axis for neurodegenerative diseases.
Wang J; Cao Y; Lu Y; Zhu H; Zhang J; Che J; Zhuang R; Shao J
Eur J Med Chem; 2024 Jan; 264():115998. PubMed ID: 38043492
[TBL] [Abstract][Full Text] [Related]
11. The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies.
Manai F; Govoni S; Amadio M
Cells; 2022 Dec; 11(24):. PubMed ID: 36552824
[TBL] [Abstract][Full Text] [Related]
12. Electrophiles Against (Skin) Diseases: More Than Nrf2.
Hennig P; Fenini G; Di Filippo M; Beer HD
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32053878
[TBL] [Abstract][Full Text] [Related]
13. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.
Takaya K; Suzuki T; Motohashi H; Onodera K; Satomi S; Kensler TW; Yamamoto M
Free Radic Biol Med; 2012 Aug; 53(4):817-27. PubMed ID: 22732183
[TBL] [Abstract][Full Text] [Related]
14. Activation of Nrf2 might reduce oxidative stress in human granulosa cells.
Akino N; Wada-Hiraike O; Terao H; Honjoh H; Isono W; Fu H; Hirano M; Miyamoto Y; Tanikawa M; Harada M; Hirata T; Hirota Y; Koga K; Oda K; Kawana K; Fujii T; Osuga Y
Mol Cell Endocrinol; 2018 Jul; 470():96-104. PubMed ID: 28986302
[TBL] [Abstract][Full Text] [Related]
15. Lights and shadows of electrophile signaling: focus on the Nrf2-Keap1 pathway.
Basagni F; Lanni C; Minarini A; Rosini M
Future Med Chem; 2019 Apr; 11(7):707-721. PubMed ID: 30942112
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate.
Satoh T; Lipton S
F1000Res; 2017; 6():2138. PubMed ID: 29263788
[TBL] [Abstract][Full Text] [Related]
17. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
Lee DH; Gold R; Linker RA
Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
[TBL] [Abstract][Full Text] [Related]
19. DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner.
Gillard GO; Collette B; Anderson J; Chao J; Scannevin RH; Huss DJ; Fontenot JD
J Neuroimmunol; 2015 Jun; 283():74-85. PubMed ID: 26004161
[TBL] [Abstract][Full Text] [Related]
20. Dimethylfumarate alleviates early brain injury and secondary cognitive deficits after experimental subarachnoid hemorrhage via activation of Keap1-Nrf2-ARE system.
Liu Y; Qiu J; Wang Z; You W; Wu L; Ji C; Chen G
J Neurosurg; 2015 Oct; 123(4):915-23. PubMed ID: 25614941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
